These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 28797565)
1. Low adherence to antidepressants is associated with increased mortality in Parkinson disease patients. Shoval G; Stubbs B; Balicer RD; Feldman B; Hoshen M; Zalsman G; Sagy R; Hochman E; Weizman A; Krivoy A Parkinsonism Relat Disord; 2017 Oct; 43():92-96. PubMed ID: 28797565 [TBL] [Abstract][Full Text] [Related]
2. Low adherence to antidepressants is associated with increased mortality following stroke: A large nationally representative cohort study. Krivoy A; Stubbs B; Balicer RD; Weizman S; Feldman B; Hoshen M; Zalsman G; Hochman E; Shoval G Eur Neuropsychopharmacol; 2017 Oct; 27(10):970-976. PubMed ID: 28886897 [TBL] [Abstract][Full Text] [Related]
3. Adherence to antidepressant medications is associated with reduced premature mortality in patients with cancer: A nationwide cohort study. Shoval G; Balicer RD; Feldman B; Hoshen M; Eger G; Weizman A; Zalsman G; Stubbs B; Golubchik P; Gordon B; Krivoy A Depress Anxiety; 2019 Oct; 36(10):921-929. PubMed ID: 31332883 [TBL] [Abstract][Full Text] [Related]
4. Adherence to antidepressant therapy and mortality rates in ischaemic heart disease: cohort study. Krivoy A; Balicer RD; Feldman B; Hoshen M; Zalsman G; Weizman A; Shoval G Br J Psychiatry; 2015 Apr; 206(4):297-301. PubMed ID: 25657353 [TBL] [Abstract][Full Text] [Related]
5. Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study. Zenesini C; Baldin E; Vignatelli L; Poluzzi E; Antonazzo I; Calandra-Buonaura G; Guarino M; De Carolis P; Cortelli P; D'Alessandro R; J Neurol Sci; 2019 Oct; 405():116421. PubMed ID: 31422283 [TBL] [Abstract][Full Text] [Related]
6. Adherence to antidepressants is associated with lower mortality: a 4-year population-based cohort study. Krivoy A; Balicer RD; Feldman B; Hoshen M; Zalsman G; Weizman A; Shoval G J Clin Psychiatry; 2016 May; 77(5):e566-72. PubMed ID: 27136668 [TBL] [Abstract][Full Text] [Related]
7. The impact of depressive symptoms in early Parkinson disease. Ravina B; Camicioli R; Como PG; Marsh L; Jankovic J; Weintraub D; Elm J Neurology; 2007 Jul; 69(4):342-7. PubMed ID: 17581943 [TBL] [Abstract][Full Text] [Related]
8. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Driver JA; Kurth T; Buring JE; Gaziano JM; Logroscino G Neurology; 2008 Apr; 70(16 Pt 2):1423-30. PubMed ID: 18413567 [TBL] [Abstract][Full Text] [Related]
9. Just keep taking the tablets: adherence to antidepressant treatment in older people in primary care. Maidment R; Livingston G; Katona C Int J Geriatr Psychiatry; 2002 Aug; 17(8):752-7. PubMed ID: 12211126 [TBL] [Abstract][Full Text] [Related]
10. [Benchmarking in patient care: depression in Parkinson's disease]. Spottke A; Schneider F; Dodel R Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):383-8. PubMed ID: 21767798 [TBL] [Abstract][Full Text] [Related]
11. Increased all-cause mortality with psychotropic medication in Parkinson's disease and controls: a national register-based study. Frandsen R; Baandrup L; Kjellberg J; Ibsen R; Jennum P Parkinsonism Relat Disord; 2014 Nov; 20(11):1124-8. PubMed ID: 25164488 [TBL] [Abstract][Full Text] [Related]
12. Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies. Huang YF; Cherng YG; Hsu SP; Yeh CC; Chou YC; Wu CH; Chen TL; Liao CC Osteoporos Int; 2015 Jun; 26(6):1723-32. PubMed ID: 25672807 [TBL] [Abstract][Full Text] [Related]
13. Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden. Reutfors J; Andersson TM; Brenner P; Brandt L; DiBernardo A; Li G; Hägg D; Wingård L; Bodén R J Affect Disord; 2018 Oct; 238():674-679. PubMed ID: 29966932 [TBL] [Abstract][Full Text] [Related]
14. Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis. Josephson CB; Lowerison M; Vallerand I; Sajobi TT; Patten S; Jette N; Wiebe S JAMA Neurol; 2017 May; 74(5):533-539. PubMed ID: 28241168 [TBL] [Abstract][Full Text] [Related]
15. Primary adherence to antidepressant prescriptions in primary health care: a population-based study in Sweden. Freccero C; Sundquist K; Sundquist J; Ji J Scand J Prim Health Care; 2016; 34(1):83-8. PubMed ID: 26828942 [TBL] [Abstract][Full Text] [Related]
16. The impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort study. Assayag J; Forget A; Kettani FZ; Beauchesne MF; Moisan J; Blais L Can J Psychiatry; 2013 Apr; 58(4):233-9. PubMed ID: 23547647 [TBL] [Abstract][Full Text] [Related]
17. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability. Smith KM; Eyal E; Weintraub D; JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207 [TBL] [Abstract][Full Text] [Related]
18. [Antidepressants consumption in the global population in France]. Olié JP; Elomari F; Spadone C; Lépine JP Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542 [TBL] [Abstract][Full Text] [Related]
19. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis. Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998 [TBL] [Abstract][Full Text] [Related]
20. Increased risk of Parkinson's disease after depression: a retrospective cohort study. Schuurman AG; van den Akker M; Ensinck KT; Metsemakers JF; Knottnerus JA; Leentjens AF; Buntinx F Neurology; 2002 May; 58(10):1501-4. PubMed ID: 12034786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]